Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults

OBJECTIVE: Pneumococcal disease is a significant problem in immunocompromised persons, particularly in HIV-infected individuals. The CDC recently updated pneumococcal vaccination recommendations for immunocompromised adults, adding the 13-valent pneumococcal conjugate vaccine (PCV13) to the previous...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Smith, Kenneth J., Nowalk, M. Patricia, Raymund, Mahlon, Zimmerman, Richard K.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742552/
https://ncbi.nlm.nih.gov/pubmed/23806240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.06.037
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares